Carevive Systems receives Series C backing from Philips Improving outcomes for people with cancer isn’t only about breakthrough treatments — it also hinges on understanding the true patient experience in order to find ways to improve it. That’s the mission of Miami-based Carevive Systems, which recently received Series C backing from Philips. Carevive aims to enable providers to deliver better quality cancer care, encourages patient engagement and improves access to new treatments. Providers use Carevive software embedded within their EMR workflows to generate personalized patient care plans — based on the best possible treatment choices — and to remotely monitor and manage patient symptoms at home. “Carevive’s suite of patient engagement and clinical cancer care management technologies are very promising and we look forward to working with the company to further improve patient care,” says Rich Wilmot, managing director of investments at Philips Ventures.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.